
|Videos|July 21, 2022
CMV Screening and Prevention
Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.
Advertisement
Advertisement
Related to this article

Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.

Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.

In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.

HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
FDA approves pritelivir tablets to treat lesions from HSV
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5



